A hospital-wide digital care pathway for atrial fibrillation was associated with lower risks of major adverse cardiovascular events and heart failure readmission at one year, according to a real-world implementation study published in BMC Cardiovascular Disorders. The study, conducted at Weifang People’s Hospital in China, evaluated a multicomponent system named OWHD-AF that integrated outpatient identification, inpatient collaborative care, and home-based follow-up using mobile health tools and artificial intelligence. The research team reported that the implementation of this pathway was linked to improved guideline-directed care processes and favorable clinical outcomes over a 12-month period.
The study utilized a before-and-after design to assess the impact of the digital pathway on patients hospitalized with atrial fibrillation. Researchers compared 5,146 patients managed before the implementation of the system in 2023 with 5,461 patients managed after its deployment in 2024. This real-world implementation approach allowed the team to observe how the integrated care model functioned within routine hospital workflows, rather than in a controlled clinical trial setting. The total cohort included 10,607 hospitalized patients, providing a substantial sample size for evaluating the pathway’s effectiveness across a diverse patient population.
The OWHD-AF pathway was designed to address the continuous, multidisciplinary, and patient-engaged management required for atrial fibrillation across screening, inpatient care, discharge transition, and long-term follow-up. The system integrated electronic medical record–based AF identification, electrocardiographic report screening, and automated clinical prompts to ensure that patients were identified and managed according to current guidelines. Fast-track electrophysiology referral and interdepartmental specialist coordination were also embedded in the workflow to facilitate timely and coordinated care. These components aimed to streamline the diagnostic and therapeutic processes for patients with atrial fibrillation.
Key elements of the pathway included guideline-directed risk assessment, anticoagulation optimization, and AI-assisted telephone follow-up. The system utilized SMS reminders and manual escalation for predefined risk signals to maintain patient engagement and safety. Dashboard-supported quality monitoring allowed clinicians to track process indicators and outcomes in real time.
Monthly process indicators were assessed using interrupted time-series analysis, which revealed significant positive slope changes after the implementation of the pathway. AF diagnosis, CHAâ‚‚DSâ‚‚-VASc assessment, and HAS-BLED assessment all showed statistically significant improvements, with all P-values less than .001. Documentation of monthly risk assessment increased from consistently low levels before implementation to more than 80% during the late post-implementation period.
The digital follow-up component of the pathway demonstrated substantial engagement metrics. The system delivered 20,932 outbound AI-assisted follow-up calls, of which 7,440 were connected, representing a connection rate of 35.5%. Additionally, 9,550 SMS reminders were sent, with 9,454 successfully delivered, achieving a delivery rate of 99.0%. These outreach and care-conversion indicators provided insight into the reach and reliability of the digital tools used in the pathway.
At 12 months, the implementation of OWHD-AF was associated with lower risks of major adverse cardiovascular events and heart failure readmission. The risk of major adverse cardiovascular events was 3.72% in the post-implementation group compared to 5.11% in the pre-implementation group, with an adjusted hazard ratio of 0.72 (95% CI 0.60–0.86; P<.001). Similarly, the risk of heart failure readmission was 3.42% versus 4.66%, with an adjusted hazard ratio of 0.71 (95% CI 0.59–0.86; P<.001). All-cause mortality was numerically lower in the post-implementation group, and major bleeding was not significantly increased.
However, as a real-world implementation study, the results should be interpreted with consideration of the study’s design and the specific context of the hospital where it was conducted.
Subject of Research: Real-world implementation and 1-year outcomes of a mobile health–enabled integrated care pathway for atrial fibrillation
Article Title: Mobile health–enabled outpatient–ward–home integrated care for atrial fibrillation: real-world implementation and 1-year outcomes of a multicomponent hospital-wide digital pathway
Article References: Fang, H., Wang, S., Hao, J., Ge, R., Guo, J., Su, L., Wang, T., Li, M., Feng, B., Han, X., Liu, K., Zhang, Y., Cai, Y., Chen, Y., & Zhang, Q. (2026). Mobile health–enabled outpatient–ward–home integrated care for atrial fibrillation: real-world implementation and 1-year outcomes of a multicomponent hospital-wide digital pathway. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-026-06699-4
Image Credits: AI Generated
DOI: 10.1186/s12872-026-06699-4
Keywords: atrial fibrillation, mobile health, digital care, hospital implementation, cardiovascular outcomes, AI follow-up, integrated care, real-world study, Mobile, health, enabled, outpatient
News Source: Ophelia Keating. (November 10, 2026). Digital AF Care Pathway Linked to Lower 1-Year Event Rates. Scienmag.



